Detalhe da pesquisa
1.
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.
J Cancer Res Clin Oncol
; 149(15): 14125-14136, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37552307
2.
Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.
JCO Precis Oncol
; 6: e2100424, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35138919
3.
Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains.
Hum Gene Ther
; 18(8): 712-25, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17685852
4.
Improved conditioning regimens for autologous transplantation using targeted radiotherapy.
Acta Haematol
; 114(4): 230-8, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16269863
5.
Purification and characterization of protein tyrosine phosphatase PTP-MEG2.
J Cell Biochem
; 86(1): 79-89, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12112018
6.
PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells.
Blood
; 102(13): 4354-60, 2003 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12920026